Back to Search
Start Over
115 The frequency of intermediate monocytes before treatment is a candidate biomarker of clinical response to secukinumab in of psoriasis
- Source :
- Journal of Investigative Dermatology; December 2022, Vol. 142 Issue: 12, Number 12 Supplement 1 pS200-S200, 1p
- Publication Year :
- 2022
Details
- Language :
- English
- ISSN :
- 0022202X and 15231747
- Volume :
- 142
- Issue :
- 12, Number 12 Supplement 1
- Database :
- Supplemental Index
- Journal :
- Journal of Investigative Dermatology
- Publication Type :
- Periodical
- Accession number :
- ejs61917317
- Full Text :
- https://doi.org/10.1016/j.jid.2022.09.125